Myriad Genetics (MYGN) PT Lowered to $4 at TD Cowen

July 31, 2026 9:09 AM

TD Cowen analyst Kyle Boucher lowered the price target on Myriad Genetics (NASDAQ: MYGN) to $4.00 (from $6.00) while maintaining a Hold rating.

No results found